Rajan Sharma

Stock Analyst at Goldman Sachs

(0.38)

# 3,943

Out of 4,670 analysts

4

Total ratings

33.33%

Success rate

-17.5%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General Biotechnology

Stocks Rated by Rajan Sharma

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	AZN AstraZeneca	Initiates: Buy	$97	$65.63	+47.80%	1	May 30, 2024
	GSK GSK	Initiates: Neutral	$47	$33.96	+38.40%	1	May 30, 2024
	IMCR Immunocore Holdings	Reiterates: Overweight	$79	$32.28	+144.73%	2	Jun 20, 2023

AstraZeneca

May 30, 2024

Initiates: Buy

Price Target: $97

Current: $65.63

Upside: +47.80%

GSK

May 30, 2024

Initiates: Neutral

Price Target: $47

Current: $33.96

Upside: +38.40%

Immunocore Holdings

Jun 20, 2023

Reiterates: Overweight

Price Target: $79

Current: $32.28

Upside: +144.73%